Osteopore Ltd
ASX:OSX

Watchlist Manager
Osteopore Ltd Logo
Osteopore Ltd
ASX:OSX
Watchlist
Price: 0.006 AUD Market Closed
Market Cap: 1.5m AUD

Osteopore Ltd
Investor Relations

Osteopore Ltd. develops and markets bioresorbable polymer implants for neurosurgical, orthopaedic and maxillofacial surgeries. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-09-23. The firm is engaged in commercializing a range of products to facilitate bone healing across multiple therapeutic areas. The company fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material using its platform technology. Its 3D print scaffold design is based on the principle of tissue engineering and regenerative medicine. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. Its craniofacial products are used as bone void fillers for regeneration of natural bone. The company also develops and manufactures implants that focuses on unmet clinical needs which improve patient outcomes. Its science of tissue engineering and regenerative medicine provides various surgical solutions for medical surgeons. Its products are used by surgeons across Asia, Europe, Australia, and the Americas.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Kei Wei Leong
Executive Chairman
No Bio Available
Dr. Yujing Lim
CEO, CTO & Executive Director
No Bio Available
Ms. Shu Ning Voon
Financial Controller
No Bio Available
Mr. Khoon Seng Goh
Global Marketing Director
No Bio Available
Mr. Jack Rosagro
Company Secretary
No Bio Available

Contacts

Address
WESTERN AUSTRALIA
Perth
Ground Floor, 16 Ord St
Contacts
+61894820500.0
www.osteopore.com